Skip to main content
Premium Trial:

Request an Annual Quote

Igentify NIPT and PGx for Digital Genetic Assistant

Digital health company Igentify has launched its noninvasive prenatal testing (NIPT) and pharmacogenomics (PGx) offerings for its Digital Genetic Assistant platform. The NIPT workflow includes a patient web-app that facilitates all aspects of patient intake, including an ACOG-compliant consenting process using Igentify's proprietary video technology to create highly personalized educational videos for each patient. The Digital Genetic Assistant also provides clinician-facing tools that enable fast triaging and return of low-risk results via personalized videos, including optional disclosure of fetal sex.

The PGx workflow encompasses raw genetic data to report, with analysis capabilities for haplotyping and star allele calling. The platform currently supports 45 pharmacogenes with a star allele call-rate of 99.7 percent, the company said.